Oral presentation: Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/ remodelling in emphysema

L.S. Mackay, L.A. Borthwick, K. Pinnion, C. Ward, J. Lordan, M. Foster, A.J. Fisher, P.A. Corris (Newcastle upon Tyne, United Kingdom)

Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Number: 19
Disease area: Interstitial lung diseases

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
L.S. Mackay, L.A. Borthwick, K. Pinnion, C. Ward, J. Lordan, M. Foster, A.J. Fisher, P.A. Corris (Newcastle upon Tyne, United Kingdom). Oral presentation: Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/ remodelling in emphysema. Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Endothelial to mesenchymal transition (EnMT) as a mechanism of alveolar septal fibrosis/remodelling in emphysema
Source: Annual Congress 2009 - Bronchoalveolar lavage and phenotyping in diffuse parenchymal lung disease
Year: 2009

Endothelial to mesenchymal transition: a precursor to post-COVID-19 interstitial pulmonary fibrosis and vascular obliteration?
Source: Eur Respir J, 56 (4) 2003167; 10.1183/13993003.03167-2020
Year: 2020



Arterial remodelling in patients with idiopathic pulmonary fibrosis (IPF) and the possible role of endothelial to mesenchymal transition (EndMT)
Source: Virtual Congress 2021 – Mechanistic pathways in chronic and new lung diseases
Year: 2021



Epithelial mesenchymal transition in fibroblastic foci of different fibrosing lung diseases: Repair or remodeling?
Source: Annual Congress 2013 –Idiopathic pulmonary fibrosis: pathogenesis
Year: 2013

IL-11 promotes pulmonary vascular remodeling and lung fibrosis through the activation of endothelial to mesenchymal transition.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020

Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis
Source: Eur Respir J 2011; 39: 133-140
Year: 2012



Parenchymal trafficking of pleural mesothelial cells in idiopathic pulmonary fibrosis
Source: Eur Respir J 2012; 39: 133-140
Year: 2012



Alveolar type II cells transplantation decrease fibrocyte migration in pulmonary fibrosis
Source: Annual Congress 2013 –Novel mechanisms in lung injury
Year: 2013


Alveolar epithelial injury and apoptosis
Source: Annual Congress 2007 - Mechanisms in pulmonary fibrosis
Year: 2007

Apoptosis of alveolar septal cells contributes to the pathogenesis of emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 75s
Year: 2001

Thyroid hormone inhibits pulmonary fibrosis through enhancement of mitochondrial function in alveolar epithelial cells
Source: International Congress 2016 – IPF: from pathogenesis to treatment I
Year: 2016


Tissue remodelling in chronic bronchial diseases: from the epithelial to mesenchymal phenotype
Source: Eur Respir Rev 2014; 23: 118-130
Year: 2014



The role of epithelial to mesenchymal transition (EMT) in airway remodelling after human lung transplantation
Source: Annual Congress 2008 - Vascular and interstitial remodelling in chronic lung disease: therapeutic interventions on the horizon
Year: 2008

Epidermal growth factor receptor (EGFR) activation is required for TGFbeta1-induced epithelial-mesenchymal transition (EMT) in idiopathic pulmonary fibrosis (IPF)
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013

Impaired tissue repair in emphysema: intrinsic defects in mesenchymal stromal cells or defects in the matrix?
Source: International Congress 2017 – Repair of the emphysematous lung: mesenchymal stromal cell and matrix interactions
Year: 2017


PDGFRa and aSMA mark two distinct mesenchymal cell populations involved in parenchymal and vascular remodeling in pulmonary fibrosis.
Source: Virtual Congress 2020 – Translational aspects of idiopathic pulmonary fibrosis
Year: 2020


Altered proliferation of alveolar epithelial cells is involved in progressive elastase-induced emphysema
Source: Annual Congress 2012 - The smoking gun in COPD biology
Year: 2012


PP206 – Modeling idiopathic pulmonary fibrosis using induced pluripotent stem cell-derived alveolar epithelial organoids
Source: ERS Lung Science Conference 2021
Year: 2021

Alveolar epithelial cell plasticity in lung injury, repair and fibrosis
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008